Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) Secure Partnership
Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) today announced a multi-year collaboration that will use TScan's proprietary target discovery platform.
Raymond Deshaies Gavin Macbeath Million Upfront With Potential Development Global Research At Amgen Research Capabilities Tscan Therapeutics Inc
Source: microcapdaily.com